65 related articles for article (PubMed ID: 8770644)
1. Generation and characterization of monoclonal antibodies against the ERGB/FLI-1 transcription factor.
Zhang XK; Papas TS; Bhat NK; Watson DK
Hybridoma; 1995 Dec; 14(6):563-9. PubMed ID: 8770644
[TBL] [Abstract][Full Text] [Related]
2. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.
Watson DK; Smyth FE; Thompson DM; Cheng JQ; Testa JR; Papas TS; Seth A
Cell Growth Differ; 1992 Oct; 3(10):705-13. PubMed ID: 1445800
[TBL] [Abstract][Full Text] [Related]
3. Production and characterization of mouse monoclonal antibodies to wild-type and oncogenic FLI-1 proteins.
Melot T; Gruel N; Doubeikovski A; Sevenet N; Teillaud JL; Delattre O
Hybridoma; 1997 Oct; 16(5):457-64. PubMed ID: 9388029
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the ETS-related transcription factor FLI-1/ERGB correlates with and can induce the megakaryocytic phenotype.
Athanasiou M; Clausen PA; Mavrothalassitis GJ; Zhang XK; Watson DK; Blair DG
Cell Growth Differ; 1996 Nov; 7(11):1525-34. PubMed ID: 8930402
[TBL] [Abstract][Full Text] [Related]
6. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation.
Hodge DR; Robinson L; Watson D; Lautenberger J; Zhang XK; Venanzoni M; Seth A
Oncogene; 1996 Jan; 12(1):11-8. PubMed ID: 8552380
[TBL] [Abstract][Full Text] [Related]
7. The FLI-1 transcription factor is a short-lived phosphoprotein in T cells.
Zhang XK; Watson DK
J Biochem; 2005 Mar; 137(3):297-302. PubMed ID: 15809330
[TBL] [Abstract][Full Text] [Related]
8. Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation.
Koizumi S; Fisher RJ; Fujiwara S; Jorcyk C; Bhat NK; Seth A; Papas TS
Oncogene; 1990 May; 5(5):675-81. PubMed ID: 2189104
[TBL] [Abstract][Full Text] [Related]
9. Characterization of monoclonal antibodies specific to the transcription factor ETS-2 protein.
Sanij E; Scott B; Wilson T; Xu D; Hertzog P; Wolvetang E
Immunol Lett; 2003 Mar; 86(1):63-70. PubMed ID: 12600747
[TBL] [Abstract][Full Text] [Related]
10. Characterization of monoclonal antibodies directed to the amino-terminus of the WT1, Wilms' tumor suppressor protein.
Rauscher FJ; Morris JF; Fredericks WJ; Lopez-Guisa J; Balakrishnan C; Jost M; Herlyn M; Rodeck U
Hybridoma; 1998 Apr; 17(2):191-8. PubMed ID: 9627060
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies directed against the amino-terminal domain of human TBP cross-react with TBP from other species.
Ruppert SM; McCulloch V; Meyer M; Bautista C; Falkowski M; Stunnenberg HG; Hernandez N
Hybridoma; 1996 Feb; 15(1):55-68. PubMed ID: 9064287
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185.
McKenzie SJ; Marks PJ; Lam T; Morgan J; Panicali DL; Trimpe KL; Carney WP
Oncogene; 1989 May; 4(5):543-8. PubMed ID: 2566965
[TBL] [Abstract][Full Text] [Related]
13. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
14. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
Barbeau B; Barat C; Bergeron D; Rassart E
Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
[TBL] [Abstract][Full Text] [Related]
15. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
16. Purification of an active TATA-binding protein-containing factor using a monoclonal antibody that recognizes the human TATA-binding protein.
Chatterjee PK; Pruzan R; Flint SJ
Protein Expr Purif; 1993 Oct; 4(5):445-55. PubMed ID: 7504537
[TBL] [Abstract][Full Text] [Related]
17. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
18. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L
Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies specific to human ETS-2 oncoprotein: recognition of epitopes clustered on the B domain.
Fujiwara S; Koizumi S; Fisher RJ; Bhat NK; Papas TS
Hybridoma; 1990 Dec; 9(6):559-71. PubMed ID: 1706313
[TBL] [Abstract][Full Text] [Related]
20. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
